Literature DB >> 9029194

Nature and site of action of endogenous nitric oxide in vasculature of isolated pig lungs.

G Cremona1, T Higenbottam, M Takao, E A Bower, L W Hall.   

Abstract

The site of action of endogenous and exogenous nitric oxide (NO) in isolated pig lungs was investigated by using arterial, double, and venous occlusions, which allowed precapillary, postcapillary, and venous segments to be partitioned into arterial, precapillary, postcapillary, and venous segments. NG-nitro-L-arginine (L-NNA; 10(-5) M) increased resistance in the arterial (35 +/- 6.6%. P = 0.003), precapillary (39.3 +/- 5.1%, P = 0.001), and venous (18.3 +/- 4.8%, P = 0.01) segments, respectively. Sodium nitroprusside (10(-5) M) NO (80 parts/million) reversed the effects of L-NNA. Total pulmonary vascular resistance fell with increasing flow, due to a fall in precapillary resistance and dynamic resistance, and was significantly lower than mean total resistance. L-NNA increased the resistances but did not alter the pattern of the pressure-flow relationships. It is concluded that, in isolated pig lungs, the effect of endogenous NO seems to be dependent on flow in the arterial segment and independent of flow in the precapillary segment, but variation of its release does not appear to be fundamental to accommodation to changes in steady flow.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029194     DOI: 10.1152/jappl.1997.82.1.23

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  The role of nitric oxide in the regulation of the systemic and pulmonary vasculature of the rattlesnake, Crotalus durissus terrificus.

Authors:  Gina L J Galli; Nini Skovgaard; Augusto S Abe; Edwin W Taylor; Tobias Wang
Journal:  J Comp Physiol B       Date:  2005-02-23       Impact factor: 2.200

Review 2.  The direct and indirect action of inhaled agents on the lung and its circulation: lessons for clinical science.

Authors:  T Higenbottam; T Siddons; E Demoncheaux
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.